Dillon Martinson

Cooley advised SoftEye, a San Diego-based company developing specialized chips, cameras, software and algorithms for use in smart glasses, on its sale to TDK Corporation, a Tokyo-based global leader in advanced electronic solutions designed for a smarter, more connected world.

Cooley advised Sanity, a content management system that helps build dynamic, content-rich experiences and streamline content workflows, on its $85 Million Series C.

Cooley advised Datadog (Nasdaq: DDOG), a monitoring and security platform for cloud applications, on its acquisition of Eppo, a feature flagging and experimentation platform that will tightly integrate with Datadog’s existing product analytics suite.

Cooley advised Cerberus Capital Management, a global leader in alternative investing with approximately $65 billion in assets across complementary credit, real estate and private equity strategies, on its growth investment in Aquatech, a global leader in water technology and services for industrial and infrastructure markets.

Cooley advised EsoBiotec, a biotechnology company pioneering in vivo cell therapies that has demonstrated promising early clinical activity, on its definitive agreement to be acquired by AstraZeneca (London Stock Exchange/Nasdaq Stockholm/Nasdaq: AZN) for up to $1 billion on a cash- and debt-free basis.